Thorax

Article	Citations
Vaping and CBD: can new technology overcome old problems?	184
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	142
Journal club	118
E-cigarette use in young adults and adolescents: not so safe?	113
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	111
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	111
Beware, vaping e-cigarettes around children is adversely impacting their lung health	94
Ablation for lung cancer: hot or cold intervention	84
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	72
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	67
Correction:British Thoracic Society Winter Meeting 2023	64
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	63
Effects of tobacco smoking on recurrent hospitalisation with pneumonia: a population-based cohort study	62
Complex coexistence of COPD and cardiovascular disease	62
British Thoracic Society Guideline for pleural disease	61
Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial	61
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	61
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	58
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	56
Lung development genes, adult lung function and cardiovascular comorbidities	54
Correction:RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock	50
Highlights from this issue	47
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis	45
Lower airway microbiota in COPD and healthy controls	45
Muscle memory: genetic factors underlying functional impairment in COPD	44

Prevalence of lung cysts in adolescents and adults with a germlineDICER1pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary B	44
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease	43
Ageing and ivacaftor: unravelling the long-term effects	43
BTS Clinical Statement on air travel for passengers with respiratory disease	42
Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark	41
Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study	41
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care	39
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review	39
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	37
Differentiation of malignant from benign pleural effusions based on artificial intelligence	37
Toxic metals and lung health: silent poisons?	37
Activation of epithelial and inflammatory pathways in adolescent elite athletes exposed to intense exercise and air pollution	36
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	36
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	36
Case of hot tub lung showing a shadow distribution consistent with unequal ventilation	35
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study	35
Functional impairment in COPD can be predicted using genomic-derived data	35
Past, present and future of conservative oxygen therapy in critical care	35
Air athletes breathe: weighing benefits against harm	34
Early experience of a new national lung allocation scheme in the UK based on clinical urgency	34
Invasive pulmonary infection caused byTrichoderma longibrachiatum	34
Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients	34
Highlights from this issue	33
Sleep-disordered breathing in children and adults with intellectual disability: mind the gap!	33
Impact of ambient air pollution on lung function in preterm-born school-aged children	33
Testosterone and lung function: bigger lungs, slower decline or some combination of both?	33
Correction:British thoracic Society Winter Meeting 2022	33
Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis	32
A syndrome by any other name: playing the long-term outcome CARDS	32
Journal club	32
Quantitative BAL: a suitable method for the assessment of epithelial lining fluid in alpha-1 antitrypsin deficiency?	32
Systematic review and meta-analysis of the efficacy of biologic and targeted synthetic therapies in sarcoidosis	31
Medical management of inpatients with tobacco dependency	31
Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study	31
Web-based physical activity promotion in young people with CF: a randomised controlled trial	31
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis	30
Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study	29
Journal club	29
British Thoracic Society Clinical Statement on pulmonary rehabilitation	29
Smart steps forward: the role of wearables in long-term rehabilitation after lung transplantation	29
Management of a complex thoracic infection, one compartment at a time	28
Returning to work following critical illness: milestone or millstone?	28
Journal club	28
Association of fluoroquinolones with the risk of spontaneous pneumothorax: nationwide case–time–control study	28
Effects of traditional mind–body movement therapy on chronic cardiopulmonary dyspnoea: a systematic review and meta-analysis	28
Heat-related hospitalisations for asthma – challenges for research	26
Comparing tests in the absence of a reference standard	26
Untangling the web between menopause and respiratory disease	26
Silicone depositions: an unusual finding in the explanted and newly transplanted lungs	26
Understanding the effectiveness of different exercise training programme designs on V̇O2peakin COPD: a component network meta-analysis	25

Comprehensive analysis of environmental exposure to hazardous trace elements and lung function: a national cross-sectional study	25
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial	25
Exploring the challenges of accessing medication for patients with cystic fibrosis	25
Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist	24
Maintaining light sedation is important: next steps for research	24
Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community	24
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment	24
Establishing the exposure–outcome relation between airborne particulate matter and children’s health	24
MAC attack: MSCs and macrophages join forces against chronic lung infection	24
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma	24
Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study	23
Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019	23
Fixing lung health in the UK: accelerating respiratory research and innovation	23
Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses	23
Journal club	22
Searching, again, for answers in all the wrong places	22
QCOVID in Scotland: time to recalibrate our expectations?	22
Combined effect of ozone and household air pollution on COPD in people aged less than 50 years old	22
COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors	22
Correction:Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data	22
Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset	21
Inequalities in care and the burden of wheeze and asthma in young children from diverse socioeconomic and ethnic backgrounds	21
Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia	21
Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline	20
Rare case of bilateral lung nodules	20
Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma	20
Home-based pulmonary rehabilitation during outpatient-managed acute COPD exacerbation: the latest new PR model?	20
MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study	20
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias	20
Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England	19
Epithelial damage and ageing: the perfect storm	19
What’s new in pleural disease?	19
Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis	19
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials	19
Highlights from this issue	19
Effect of time of day and seasonal variation on bronchodilator responsiveness: the SPIRO-TIMETRY study	19
Evaluation of a health and social care programme to improve outcomes following critical illness: a multicentre study	19
Correction: BTS clinical statement on pulmonary sarcoidosis	19
Highlights from this issue	18
Does impaired respiratory function lead to sudden cardiac death?	18
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial	18
New statement and new hope for patients with refractory chronic cough	18
Pulmonary arterio-venous malformation on endobronchial ultrasound bronchoscopy	18
Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?	18
Correction: What’s hot that the other lot got	18
Time to move out of the shadows: ILA in patients with lung cancer	18
Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality	17
Novel electromagnetic navigation bronchoscopy system for the diagnosis of peripheral pulmonary nodules: a prospective, multicentre study	17
Sex differences in COPD in relation to smoking exposure: a population-based cohort study	17
Effect of quitting smoking on health outcomes during treatment for tuberculosis: secondary analysis of the TB & Tobacco Trial	17
Use of inhaled corticosteroids and risk of acquiringPseudomonas aeruginosain patients with chronic obstructive pulmonary disease	17
Challenging the gold standard: the limitations of molecular assays for detection ofMycobacterium tuberculosisheteroresistance	17
Classifying ARDS by dynamic or static oxygenation impairment or are other approaches needed for greater value	16
Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help?	16
Children’s charter for lung health	16
Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey	16
Atopic and non-atopic effects of fish oil supplementation during pregnancy	16
Circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis: a new association	16
Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis	16
Computational fluid dynamics model predictions of inhaled corticosteroid deposition in patients with severe asthma	16
British Thoracic Society Guideline for diagnosing and monitoring paediatric sleep-disordered breathing	16
High-flow nasal oxygen: benefits are hard to show in COVID-19 patients with mild hypoxaemia	16
Donor lung allocation scheme: how can we measure success?	15
Collagen neoepitopes in sarcoidosis: what do they tell us?	15
Multiple intrathoracic extramedullary haematopoiesis as visualised on medical thoracoscopy	15
Journal club	15
To progress or not to progress: new insights into the evolution of pleuropulmonary blastomas come from studying lung cysts in adolescents and adults withDICER1-related tumour predisposition	15
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL)	14
Bacterial biofilms predominate in both acute and chronic human lung infections	14
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study	14
Reversible bronchiectasis	14
Correction: British Thoracic Society Winter Meeting February 2021	14
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease	14
Effects of enhanced recovery after surgery plus pulmonary rehabilitation on complications after video-assisted lung cancer surgery: a multicentre randomised controlled trial	14
Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial	14
Angiosarcoma of the pulmonary artery as an unexpected evolution of an apparent pulmonary thromboembolism	14
Advanced MicroRNA delivery for lung inflammatory therapy: surfactant protein A controls cellular internalisation and degradation of extracellular vesicles	14
Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis	14
Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia	14
Role of inflammasomes in acute respiratory distress syndrome	14

Correction:Night shift work is associated with an increased risk of asthma	13
Highlights from this issue	13
Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis	13
Immediate smoking cessation support during lung cancer screening: long-term outcomes from two randomised controlled trials	13
Journal club	13
Improving uptake of lung cancer screening: an observational study on the impact of timed appointments and reminders	13
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	13
Artificial stone silicosis arrives in the UK: a tragic case of history repeating	13
Assessing causal relationships between diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomisation study	13
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study	13
Opportunistic actinomycosis in pulmonary alveolar proteinosis	12
Journal club	12
Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial	12
Respiratory and allergic outcomes among 5-year-old children exposed to pesticides	12
Respiratory research in the UK: investing for the next 10 years	12
Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis	12
Risk of hypersensitivity pneumonitis and other interstitial lung diseases following organic dust exposure	12
Remote vision-based digital patient monitoring of pulse and respiratory rates in acute medical wards	12
Consolidation with pseudocavitation	12
Improvements of the shape and strength of the diaphragm after endoscopic lung volume reduction	12
Breathlessness across generations: results from the RHINESSA generation study	12
Definition of diaphragmatic sleep disordered breathing and clinical meaning in Duchenne muscular dystrophy	11
Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data	11
Combining tuberculin skin test with follow-on interferon gamma release assay markedly improves screening of household contacts	11
Journal club	11
Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two national cohorts	11
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy	11
Journal club	11
Higher exhaled nitric oxide at 6 weeks of age is associated with less bronchiolitis and wheeze in the first 12 months of age	11
Optimising breathlessness triggered services for older people with advanced diseases: a multicentre economic study (OPTBreathe)	11
Altered purine metabolism at reperfusion affects clinical outcome in lung transplantation	11
Journal club	11
Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease	11
Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study	10
Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis	10
Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes	10
Post-pandemic tuberculosis incidence: potential success of active case finding?	10
Higher SARS-CoV-2 detection of oropharyngeal compared with nasopharyngeal or saliva specimen for molecular testing: a multicentre randomised comparative accuracy study	10
Childhood interstitial lung disease: short lessons from telomeres	10
Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease	10
Environmental pollutants exposure-derived extracellular vesicles: crucial players in respiratory disorders	10
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis	10
Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis	10
Spontaneous intrapulmonary haemorrhage in vascular Ehlers-Danlos syndrome	10
Impacts of sex and gender on severe asthma	10
Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease	10
British Thoracic Society Clinical Statement on occupational asthma	10
Future risk projection to engage ‘near-miss’ individuals in lung cancer screening eligibility: an analysis of ILST data	10
Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis	10
Persistent hypoxaemia and a headache in a previously healthy 11-year-old girl	10
Antenatal exposures to tobacco and biomass or fossil fuels and wheezing in early childhood in South Africa	9
What shall we learn from TEACH?	9
Immune responses to SARS-CoV-2 in the lung	9
Cardiac MRI in the assessment of chronic thromboembolic pulmonary hypertension and response to treatment	9
Antibiotic pharmacokinetics in infected pleural effusions	9
Metabolomic differences in lung function metrics: evidence from two cohorts	9
Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease	9
Rare occurrence of tracheal acinic cell carcinoma causing central airway obstruction in a young adult	9
Airway inflammation in severe asthmatics with acid gastro-oesophageal reflux	9
Highlights from this issue	9
Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study	9
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)	9
Decoding pulmonary nodules: can machine learning enhance malignancy risk stratification?	9
Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial	9
One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?	9
Extensive airway remodelling in severe COPD imparts resiliency to environmental stressors	9
Tracheal stenosis after endobronchial ultrasound-guided transbronchial needle aspiration	9
Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial	9
In search of the elusive biomarker(s): a proteomics analysis in rheumatoid arthritis-associated interstitial lung disease	9
Associations of ultrafine and fine particles with childhood emergency room visits for respiratory diseases in a megacity	9
Cost-related non-adherence to medications among adults with asthma in the USA, 2011–2022	9
Understanding the aetiology of lung function impairment: the crucial role of age of onset	9
Chronic berylliosis disease: uncommon pulmonary granulomas beyond sarcoidosis	9